Inozyme Pharma ^Investor

Clinical-stage rare disease biopharmaceutical companyInozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and | Inozyme Pharma Inc. & Executives - ?